David E Ambrose
Impact in
Papers in
- Co-authors
- Bruce L. Levine (6 shared papers)Carl H. June (6 shared papers)Simon Francis Lacey (6 shared papers)Jan Joseph Melenhorst (6 shared papers)Vanessa E. Gonzalez (2 shared papers)Noelle V. Frey (3 shared papers)Stephan A. Grupp (3 shared papers)Michael C. Milone (2 shared papers)
- Journals
- Blood (8 papers)Nature (2 papers)Nature Medicine (2 papers)Science Translational Medicine (1 paper)
- Partner nations
- United States
In The Last Decade
David E Ambrose
13 papers receiving 5.4k citations
David E Ambrose's Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 4.4k
- Genetics 341
- Immunology 645
- Hematology 243
- Virology 27
Countries citing papers authored by David E Ambrose
This map shows the geographic impact of David E Ambrose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E Ambrose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E Ambrose more than expected).
Fields of papers citing papers by David E Ambrose
This network shows the impact of papers produced by David E Ambrose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E Ambrose. The network helps show where David E Ambrose may publish in the future.
Co-authors
The 25 scholars most cited alongside David E Ambrose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia Hit paper breakdown → | 2015 | 1487 |
| 2 | Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia Hit paper breakdown → | 2018 | 1435 |
| 3 | Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells Hit paper breakdown → | 2018 | 744 |
| 4 | Decade-long leukaemia remissions with persistence of CD4+ CAR T cells Hit paper breakdown → | 2022 | 722 |
| 5 | Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell Hit paper breakdown → | 2018 | 541 |
| 6 | 2016 | 430 | |
| 7 | 2016 | 65 | |
| 8 | 2016 | 43 | |
| 9 | 2016 | 30 | |
| 10 | 2015 | 26 | |
| 11 | 2013 | 19 | |
| 12 | 2016 | 17 | |
| 13 | 2016 | 17 |
About David E Ambrose
David E Ambrose is a scholar working on Oncology, Genetics, Hematology, Psychiatry and Mental health and Nuclear Energy and Engineering, having authored 13 papers that have together received 5.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (13 papers), Chronic Lymphocytic Leukemia Research (1 paper), Neurological Complications and Syndromes (1 paper) and Multiple Myeloma Research and Treatments (1 paper). The work is most often cited by research in Oncology (4.4k citations), Genetics (341 citations), Immunology (645 citations), Hematology (243 citations) and Virology (27 citations). David E Ambrose has collaborated with scholars based in United States. Frequent co-authors include Bruce L. Levine, Carl H. June, Simon Francis Lacey, Jan Joseph Melenhorst, Vanessa E. Gonzalez, Noelle V. Frey, Stephan A. Grupp, Michael C. Milone, Zhaohui Zheng and Wei‐Ting Hwang. Their work appears in journals such as Blood, Nature, Nature Medicine and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.